These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12547019)

  • 21. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nasal drug delivery--possibilities, problems and solutions.
    Illum L
    J Control Release; 2003 Feb; 87(1-3):187-98. PubMed ID: 12618035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal formulations for drug administration and characterization of nasal preparations in drug delivery.
    Scherließ R
    Ther Deliv; 2020 Mar; 11(3):183-191. PubMed ID: 32046624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
    Selvaraj K; Gowthamarajan K; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane.
    Kaur P; Garg T; Rath G; Goyal AK
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(4):1167-76. PubMed ID: 25749276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery.
    Kanazawa T; Fukuda M; Suzuki N; Suzuki T
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates.
    Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F
    Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
    Keller LA; Merkel O; Popp A
    Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies for the delivery of antidiabetic drugs via intranasal route.
    Dholakia J; Prabhakar B; Shende P
    Int J Pharm; 2021 Oct; 608():121068. PubMed ID: 34481011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs.
    Yarragudi SB; Richter R; Lee H; Walker GF; Clarkson AN; Kumar H; Rizwan SB
    Carbohydr Polym; 2017 May; 163():216-226. PubMed ID: 28267500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery.
    Battaglia L; Panciani PP; Muntoni E; Capucchio MT; Biasibetti E; De Bonis P; Mioletti S; Fontanella M; Swaminathan S
    Expert Opin Drug Deliv; 2018 Apr; 15(4):369-378. PubMed ID: 29338427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal drug administration: potential for targeted central nervous system delivery.
    Graff CL; Pollack GM
    J Pharm Sci; 2005 Jun; 94(6):1187-95. PubMed ID: 15858850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.